fda2 min read
FDA Warns GLP-1s May Increase Risk of Sudden Blindness
An anonymous reader quotes a report from NBC News: The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.
By BeauHDSlashdot

Read the full story
Originally published by Slashdot on Nov 10, 2026.
Comments
Sign in to join the discussion.